Literature DB >> 15742374

Onset and course of chronic inflammatory demyelinating polyneuropathy.

A Mygland1, P Monstad, C Vedeler.   

Abstract

Chronic inflammatory demyelinating polyneuropathy (CIDP) is clinically heterogeneous. Our purpose was to determine whether initial progression time, clinical features, and distribution of nerve conduction slowing at presentation correlate with clinical course and prognosis. We examined how findings at presentation related to clinical course during an average follow-up time of 4.0 (range 1.0-9.0) years in 44 patients with CIDP. We calculated terminal latency index (TLI), a measure of differential slowing in distal relative to more proximal nerve segments. Patients with acute or subacute onset (progression over less than 8 weeks) had a higher remission rate (P = 0.012) than patients with chronic onset (progression over more than 8 weeks). Patients with proximal weakness had a higher remission rate than patients with the distal phenotype (P < 0.001). All 5 patients with a relapsing course had subacute onset. They had lower TLIs, suggesting a more distal pattern of demyelination, than patients with a monophasic or chronic course. In conclusion, subacute onset and presence of proximal weakness are good prognostic signs that correlate with a high rate of recovery to normal in CIDP. Distal accentuation of conduction slowing at presentation correlates with subacute onset and a relapsing course.

Entities:  

Mesh:

Year:  2005        PMID: 15742374     DOI: 10.1002/mus.20297

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  6 in total

1.  Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases.

Authors:  S Kuwabara; S Misawa; M Mori; N Tamura; M Kubota; T Hattori
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

2.  Early predictive factors of disability in CIDP.

Authors:  Emanuele Spina; Antonietta Topa; Rosa Iodice; Stefano Tozza; Lucia Ruggiero; Raffaele Dubbioso; Marcello Esposito; Dario Bruzzese; Lucio Santoro; Fiore Manganelli
Journal:  J Neurol       Date:  2017-08-02       Impact factor: 4.849

3.  Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy.

Authors:  A Chiò; D Cocito; E Bottacchi; C Buffa; M Leone; F Plano; R Mutani; A Calvo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-05-10       Impact factor: 10.154

4.  Monocentric study of 28 cases of chronic inflammatory demyelinating polyneuropathy: first Tunisian study.

Authors:  Malek Mansour; Amine Rachdi; Nesrine Baradai; Amel Kacem; Ines Bedoui; Ridha Mrissa
Journal:  Neurol Sci       Date:  2021-05-04       Impact factor: 3.307

5.  MRI of the cervical nerve roots in the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy: a single-institution, retrospective case-control study.

Authors:  Kanta Tanaka; Nobuyuki Mori; Yusuke Yokota; Toshihiko Suenaga
Journal:  BMJ Open       Date:  2013-08-30       Impact factor: 2.692

Review 6.  Treatment of chronic inflammatory demyelinating polyneuropathy: from molecular bases to practical considerations.

Authors:  Paolo Ripellino; Thomas Fleetwood; Roberto Cantello; Cristoforo Comi
Journal:  Autoimmune Dis       Date:  2014-01-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.